American Society Of Nephrology publiczne
[search 0]
Więcej
Download the App!
show episodes
 
Clinical Journal of the American Society of Nephrology (CJASN) publishes high quality research relevant to clinical nephrology. Now one of the most widely-read and referenced kidney journals, physicians read CJASN to learn about the most important advances in clinical and translational research in nephrology.
  continue reading
 
Loading …
show series
 
In this podcast, Drs. Wong and Chotivatanapong summarize the main findings from their study on "Nephrology Providers' Experiences Discussing Care for Patients with Kidney Failure who Forgo Kidney Replacement Therapy: National Qualitative Study"Autor: American Society of Nephrology
  continue reading
 
CJASN editors highlight three articles centered on the theme of CKD, including articles on SGLT2 inhibitors in CKD patients; SGLT2 inhibitors and cardiovascular death in CKD; and smartphone intervention for lifestyle and hypertension management in CKD.Autor: American Society of Nephrology
  continue reading
 
Drs. Rhee, Roshanravan, and Nigwekar highlight three cutting-edge dialysis articles on pediatric ESKD iron store biomarkers; HDF, HD, and β-2-microglobulin kinetics; and development of a novel kidney replacement therapy awareness instrument.Autor: American Society of Nephrology
  continue reading
 
CJASN Editor-in-Chief Rajnish Mehrotra interviews Tristan de Nattes, the 2023 CJASN Trainee of the Year second-place winner, on his article, "A Simple Molecular Tool for the Assessment of Kidney Transplant Biopsies."Autor: American Society of Nephrology
  continue reading
 
CJASN Editor-in-Chief Rajnish Mehrotra interviews 2023 CJASN Trainee of the Year winner Rosa D. Wouda on her article, "Kaliuresis and Intracellular Uptake of Potassium with Potassium Citrate and Potassium Chloride Supplements."Autor: American Society of Nephrology
  continue reading
 
CJASN Editor-in-Chief Rajnish Mehrotra interviews 2022 CJASN Trainee of the Year winner Bart J. Kramers on his article, "Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD."Autor: American Society of Nephrology
  continue reading
 
Loading …

Skrócona instrukcja obsługi